The Journal of Antibiotics
Online ISSN : 1881-1469
Print ISSN : 0021-8820
ISSN-L : 0021-8820
Structures of ADP-Ribosylated Rifampicin and Its Metabolite: Intermediates of Rifampicin-ribosylation by Mycobacterium smegmatis DSM43756
NAOKO MORISAKI, YUICHI HASHIMOTO, KAZUO FURIHATA, TAMAE IMAI, KAYO WATANABE, YUZURU MIKAMI, KATSUKIYO YAZAWA, AKIKAZU ANDO, YOSHIHO NAGATA, ERIC R. DABBS
Author information
JOURNAL FREE ACCESS

2000 Volume 53 Issue 3 Pages 269-275

Details
Abstract
23-(O-ADP-Ribosyl)rifampicin [RIP-TAs (3, Na+ form), RIP-TAf (4, H+ form)] was obtained as an intermediate in the conversion process of rifampicin (1) to RIP-Mb (2) that is mediated by cell homogenates of Mycobacterium smegmatis DSM43756 or of Escherichia coli carrying a mycobacterial mono(ADP-ribosyl) transferase gene, in the presence of NADH. 23-[O-(5'-Phosphoribosyl)]rifampicin (5, RIP-TAp) was also obtained by the reaction of rifampicin with NADH in the presence of a homogenate of M. smegmatis. The structures of 3, 4, and 5 were determined by means of MS and NMR analyses.
Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top